What to expect when you take Nasonex and Xanax xr?

Do you take Nasonex and Xanax xr? Find out below what new side effects and undetected conditions people who are 50-59 years old may have. This prediction is created after we perform predictive analysis on health care big data. It will be updated regularly.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.



On Mar, 22, 2019

30,871 reports have been studied.


Females aged 50 to 59 :

21,404 related reports were analyzed:

Most common symptoms:

Asthma
  • 5.98% for females aged 50 (±5) who take Nasonex
Back pain
  • 5.89% for females aged 50 (±5) who take Nasonex
Chest pain
  • 7.94% for females aged 50 (±5) who take Nasonex
Cough
  • 6.31% for females aged 50 (±5) who take Nasonex
Depression
  • 6.45% for females aged 50 (±5) who take Nasonex
  • 6.04% for females aged 50 (±5) who take Xanax xr
Diarrhea
  • 6.68% for females aged 50 (±5) who take Nasonex
  • 5.3% for females aged 50 (±5) who take Xanax xr
Dizziness
  • 5.93% for females aged 50 (±5) who take Nasonex
  • 5.54% for females aged 50 (±5) who take Xanax xr
Drug ineffective
  • 7.33% for females aged 50 (±5) who take Nasonex
  • 6.53% for females aged 50 (±5) who take Xanax xr
Dyspnea
  • 10.04% for females aged 50 (±5) who take Nasonex
  • 5.63% for females aged 50 (±5) who take Xanax xr
Fall
  • 6.54% for females aged 50 (±5) who take Nasonex
Fatigue
  • 8.13% for females aged 50 (±5) who take Nasonex
  • 7.48% for females aged 50 (±5) who take Xanax xr
Headache
  • 9.95% for females aged 50 (±5) who take Nasonex
  • 6.53% for females aged 50 (±5) who take Xanax xr
High blood pressure
  • 5.79% for females aged 50 (±5) who take Nasonex
Hypoaesthesia
  • 5.18% for females aged 50 (±5) who take Nasonex
Insomnia
  • 5.33% for females aged 50 (±5) who take Xanax xr
  • 5.04% for females aged 50 (±5) who take Nasonex
Joint pain
  • 6.31% for females aged 50 (±5) who take Nasonex
Malaise
  • 5.51% for females aged 50 (±5) who take Nasonex
Nausea
  • 12.05% for females aged 50 (±5) who take Nasonex
  • 9.54% for females aged 50 (±5) who take Xanax xr
Nausea and vomiting
  • 6.4% for females aged 50 (±5) who take Nasonex
Pain
  • 8.17% for females aged 50 (±5) who take Nasonex
  • 7.38% for females aged 50 (±5) who take Xanax xr
Pain in extremity
  • 5.65% for females aged 50 (±5) who take Nasonex
Rashes
  • 7.43% for females aged 50 (±5) who take Nasonex
Sinusitis
  • 7.52% for females aged 50 (±5) who take Nasonex
Stress and anxiety
  • 8.17% for females aged 50 (±5) who take Nasonex
  • 7.95% for females aged 50 (±5) who take Xanax xr
Weakness
  • 6.08% for females aged 50 (±5) who take Xanax xr
  • 5.23% for females aged 50 (±5) who take Nasonex

Most common co-existing conditions:

Asthma
  • 13.73% for females aged 50 (±5) who take Nasonex
Depression
  • 14.28% for females aged 50 (±5) who take Xanax xr
  • 5.46% for females aged 50 (±5) who take Nasonex
Gastroesophageal reflux disease
  • 6.59% for females aged 50 (±5) who take Nasonex
High blood cholesterol
  • 5.6% for females aged 50 (±5) who take Nasonex
  • 5.38% for females aged 50 (±5) who take Xanax xr
High blood pressure
  • 8.04% for females aged 50 (±5) who take Xanax xr
  • 8.03% for females aged 50 (±5) who take Nasonex
Hypersensitivity
  • 8.55% for females aged 50 (±5) who take Nasonex
Insomnia
  • 5.4% for females aged 50 (±5) who take Xanax xr
Multiple sclerosis
  • 5.47% for females aged 50 (±5) who take Xanax xr
  • 5.37% for females aged 50 (±5) who take Nasonex
Pain
  • 9.34% for females aged 50 (±5) who take Xanax xr
  • 6.35% for females aged 50 (±5) who take Nasonex
Rheumatoid arthritis
  • 6.73% for females aged 50 (±5) who take Nasonex
  • 5.27% for females aged 50 (±5) who take Xanax xr
back to top

Males aged 50 to 59 :

9,467 related reports were analyzed:

Most common symptoms:

Dehydration
  • 5.24% for males aged 50 (±5) who take Nasonex
Depression
  • 5.16% for males aged 50 (±5) who take Xanax xr
Dizziness
  • 5.01% for males aged 50 (±5) who take Nasonex
Drug abuse and dependence
  • 5.82% for males aged 50 (±5) who take Xanax xr
Drug ineffective
  • 5.89% for males aged 50 (±5) who take Xanax xr
Dyspnea
  • 7.06% for males aged 50 (±5) who take Nasonex
  • 5.26% for males aged 50 (±5) who take Xanax xr
Fatigue
  • 7.31% for males aged 50 (±5) who take Xanax xr
  • 6.83% for males aged 50 (±5) who take Nasonex
High blood pressure
  • 6.49% for males aged 50 (±5) who take Nasonex
Nausea
  • 6.4% for males aged 50 (±5) who take Xanax xr
  • 5.92% for males aged 50 (±5) who take Nasonex
Pain
  • 5.08% for males aged 50 (±5) who take Xanax xr
Stress and anxiety
  • 6.57% for males aged 50 (±5) who take Xanax xr
  • 5.24% for males aged 50 (±5) who take Nasonex

Most common co-existing conditions:

Asthma
  • 14.24% for males aged 50 (±5) who take Nasonex
Depression
  • 11.6% for males aged 50 (±5) who take Xanax xr
  • 5.01% for males aged 50 (±5) who take Nasonex
Gastroesophageal reflux disease
  • 5.81% for males aged 50 (±5) who take Nasonex
High blood cholesterol
  • 9.11% for males aged 50 (±5) who take Nasonex
  • 5.61% for males aged 50 (±5) who take Xanax xr
High blood pressure
  • 8.66% for males aged 50 (±5) who take Nasonex
  • 7.21% for males aged 50 (±5) who take Xanax xr
Hypersensitivity
  • 6.38% for males aged 50 (±5) who take Nasonex
Pain
  • 9.3% for males aged 50 (±5) who take Xanax xr
back to top

Do you take Nasonex and Xanax xr:

  • To personalize this prediction to you, including to your gender, age, personal and family history, and more: Click here

Related studies

Nasonex

Nasonex has active ingredients of mometasone furoate monohydrate. It is often used in allergies. (latest outcomes from Nasonex 22,663 users)

Xanax xr

Xanax xr has active ingredients of alprazolam. It is often used in stress and anxiety. (latest outcomes from Xanax xr 1,283 users)

General study

Recent updates

Recent general studies
Recent personal studies

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on ePatient.care is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the ePatient.care site and its content is at your own risk.